1. Home
  2. IART vs FTRE Comparison

IART vs FTRE Comparison

Compare IART & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$13.60

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.38

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IART
FTRE
Founded
1989
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
IART
FTRE
Price
$13.60
$17.38
Analyst Decision
Hold
Buy
Analyst Count
7
9
Target Price
$15.00
$15.56
AVG Volume (30 Days)
774.3K
1.3M
Earning Date
02-24-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,642,966,000.00
$2,759,900,000.00
Revenue This Year
$3.26
$3.17
Revenue Next Year
$2.71
$0.11
P/E Ratio
N/A
N/A
Revenue Growth
4.99
1.88
52 Week Low
$10.87
$3.97
52 Week High
$27.13
$19.53

Technical Indicators

Market Signals
Indicator
IART
FTRE
Relative Strength Index (RSI) 60.39 66.77
Support Level $11.86 $16.91
Resistance Level $14.12 $18.26
Average True Range (ATR) 0.54 0.89
MACD 0.12 -0.18
Stochastic Oscillator 81.85 56.62

Price Performance

Historical Comparison
IART
FTRE

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: